Acumen Pharmaceuticals Inc (ABOS) — Long-term Investment Intensity
Acumen Pharmaceuticals Inc (ABOS) has a Long-term Investment Intensity of 6.6% as of September 2025. Long-term investments of $9.44 Million represent 6.6% of total assets of $142.22 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ABOS net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Acumen Pharmaceuticals Inc Long-term Investment Intensity (2021–2024)
This chart shows how Acumen Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 6.6%, reflecting long-term investments of $9.44 Million against total assets of $142.22 Million USD. Also explore Acumen Pharmaceuticals Inc total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Acumen Pharmaceuticals Inc (2021–2024)
The table below presents the year-by-year Long-term Investment Intensity for Acumen Pharmaceuticals Inc from 2021 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Acumen Pharmaceuticals Inc market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 25.1% | $59.97 Million | $238.99 Million | ▲ +4.9 pp |
| 2023 | 20.2% | $62.55 Million | $310.12 Million | ▲ +12.1 pp |
| 2022 | 8.1% | $15.84 Million | $196.59 Million | ▼ -5.7 pp |
| 2021 | 13.7% | $31.62 Million | $230.33 Million | — |